THC Share Price | Tenet Healthcare Corp. Stock Analysis & Recommendation

Q: What does Tenet Healthcare Corp. do?

Overview:Tenet Healthcare Corporation is a diversified healthcare services company operating in the hospital industry within the mid-cap market.Financial Snapshot:Most recent Net Sales: 5,223 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 622 Million (Quarterly Results - Mar 2025) Market-cap: USD 23,648.40 Million (Mid Cap)Key Metrics:P/E: 10.00 Dividend Yield: 0.00% Debt Equity: 2.43 Return on Equity: 59.01% Price to Book: 5.66Contact Details:Address: 14201 DALLAS PARKWAY, DALLAS TX: 75254 Tel: 1 469 8932200 Website: https://www.tenethealth.com/

Q: Who are in the management team of Tenet Healthcare Corp.?

As of March 2022, the management team of Tenet Healthcare Corp. includes the following key individuals:- Mr. Ronald Rittenmeyer, who serves as the Executive Chairman of the Board and Chief Executive Officer.- Dr. Saumya Sutaria, who holds the positions of President, Chief Operating Officer, and Director.Additionally, the Board of Directors includes Adm. Cecil Haney, Gen. Lloyd Austin, Mr. James Bierman, Mr. Richard Fisher, and Ms. Meghan FitzGerald, all of whom are independent directors.

Q: Is Tenet Healthcare Corp. technically bullish or bearish?

As of 26 August 2025, the technical trend for Tenet Healthcare Corp. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, and moving averages are bullish on a daily basis. Additionally, the Dow Theory confirms a bullish trend on both weekly and monthly levels. However, the KST shows a mildly bearish signal on both time frames, indicating some caution. In terms of performance, Tenet Healthcare has outperformed the S&P 500 over multiple periods, with a year-to-date return of 50.75% compared to the S&P 500's 12.22%, and a three-year return of 222.31% versus 70.41% for the benchmark.

Q: Is Tenet Healthcare Corp. overvalued or undervalued?

As of 24 October 2025, the valuation grade for Tenet Healthcare Corp. has moved from expensive to fair. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 10, while the EV to EBITDA ratio is 8.89 and the Price to Book Value is 5.79. In comparison to its peers, Tenet Healthcare Corp. has a P/E ratio of 10.41 and an EV to EBITDA ratio of 9.11, indicating that it is competitively positioned within the industry. Notably, the company's ROE is exceptionally high at 59.01%, suggesting strong profitability relative to shareholder equity. Over the past year, Tenet has outperformed the S&P 500 with a return of 39.24% compared to the index's 16.90%, reinforcing the notion that the stock is fairly valued given its performance.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.02 M

Shareholding (Dec 2025)

FII

12.09%

Held by 253 FIIs

DII

36.64%

Held by 61 DIIs

Promoter

0.54%

How big is Tenet Healthcare Corp.?

22-Jun-2025

As of Jun 18, Tenet Healthcare Corp. has a market capitalization of $23.65 billion, with net sales of $20.52 billion and a net profit of $2.35 billion over the latest four quarters. The balance sheet shows shareholder's funds of $4.17 billion and total assets of $28.94 billion.

View full answer

What does Tenet Healthcare Corp. do?

22-Jun-2025

Tenet Healthcare Corporation is a mid-cap diversified healthcare services company primarily operating in the hospital industry, with recent net sales of $5.2 billion and a net profit of $622 million. The company has a market cap of $23.6 billion and key metrics include a P/E ratio of 10.00 and a return on equity of 59.01%.

View full answer

Who are in the management team of Tenet Healthcare Corp.?

22-Jun-2025

As of March 2022, Tenet Healthcare Corp.'s management team includes Mr. Ronald Rittenmeyer as Executive Chairman and CEO, and Dr. Saumya Sutaria as President and COO. The Board of Directors features independent members such as Adm. Cecil Haney and Gen. Lloyd Austin.

View full answer

Is Tenet Healthcare Corp. technically bullish or bearish?

20-Sep-2025

As of August 26, 2025, Tenet Healthcare Corp. is in a bullish trend supported by strong MACD and moving averages, despite a mildly bearish KST signal, and has significantly outperformed the S&P 500 with a year-to-date return of 50.75%.

View full answer

Is Tenet Healthcare Corp. overvalued or undervalued?

28-Oct-2025

As of October 24, 2025, Tenet Healthcare Corp. is fairly valued with a P/E ratio of 10, an EV to EBITDA ratio of 8.89, and a high ROE of 59.01%, while outperforming the S&P 500 with a return of 39.24% over the past year.

View full answer

Compare Tenet Healthcare Corp. with Similar Stocks

Chemed Corp.Universal Health Services, Inc.HCA Healthcare, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Flat results in Jun 25

NET PROFIT(HY) At USD 765.55 MM has Grown at -68.97%

With ROCE of 21.26%, it has a very expensive valuation with a 2.40 Enterprise value to Capital Employed

Consistent Returns over the last 3 years

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

USD 29,670 Million (Mid Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

2.39

Return on Equity

60.21%

Price to Book

7.03

Revenue and Profits:

Net Sales:

5,527 Million

(Quarterly Results - Dec 2025)

Net Profit:

644 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

3.08%

6 Months

5.29%

1 Year

59.86%

2 Years

99.59%

3 Years

263.88%

4 Years

128.5%

5 Years

276.74%

Tenet Healthcare Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.85%

EBIT Growth (5y)

22.28%

EBIT to Interest (avg)

2.62

Debt to EBITDA (avg)

4.05

Net Debt to Equity (avg)

2.43

Sales to Capital Employed (avg)

1.23

Tax Ratio

19.70%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

16.26%

ROE (avg)

318.48%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.03

EV to EBIT

11.56

EV to EBITDA

9.24

EV to Capital Employed

2.78

EV to Sales

1.87

PEG Ratio

Dividend Yield

ROCE (Latest)

24.02%

ROE (Latest)

60.21%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 123 Schemes (50.67%)

Foreign Institutions

Held by 253 Foreign Institutions (12.09%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 4.50% vs 0.34% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 11.23% vs 10.92% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,527.00",
          "val2": "5,289.00",
          "chgp": "4.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,100.00",
          "val2": "1,035.00",
          "chgp": "6.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "205.00",
          "val2": "206.00",
          "chgp": "-0.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-98.00",
          "val2": "-12.00",
          "chgp": "-716.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "644.00",
          "val2": "579.00",
          "chgp": "11.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "157.20%",
          "val2": "154.50%",
          "chgp": "0.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.12% vs 0.57% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -41.76% vs 209.99% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21,310.00",
          "val2": "20,665.00",
          "chgp": "3.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,302.00",
          "val2": "3,725.00",
          "chgp": "15.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "821.00",
          "val2": "826.00",
          "chgp": "-0.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-198.00",
          "val2": "-135.00",
          "chgp": "-46.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,367.00",
          "val2": "4,064.00",
          "chgp": "-41.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "161.40%",
          "val2": "140.70%",
          "chgp": "2.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

5,527.00

5,289.00

4.50%

Operating Profit (PBDIT) excl Other Income

1,100.00

1,035.00

6.28%

Interest

205.00

206.00

-0.49%

Exceptional Items

-98.00

-12.00

-716.67%

Consolidate Net Profit

644.00

579.00

11.23%

Operating Profit Margin (Excl OI)

157.20%

154.50%

0.27%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.50% vs 0.34% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 11.23% vs 10.92% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

21,310.00

20,665.00

3.12%

Operating Profit (PBDIT) excl Other Income

4,302.00

3,725.00

15.49%

Interest

821.00

826.00

-0.61%

Exceptional Items

-198.00

-135.00

-46.67%

Consolidate Net Profit

2,367.00

4,064.00

-41.76%

Operating Profit Margin (Excl OI)

161.40%

140.70%

2.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 3.12% vs 0.57% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -41.76% vs 209.99% in Dec 2024

All Annual Results

Company CV

About Tenet Healthcare Corp.

Tenet Healthcare Corp.

Hospital

Tenet Healthcare Corporation is a diversified healthcare services company. The Company’s segments include Hospital Operations and other (Hospital Operations) segment, Ambulatory Care segment and Conifer segment. Through its subsidiaries, partnerships and joint ventures, including USPI Holding Company, Inc. (USPI), The Company operates approximately 65 hospitals and more than 520 other healthcare facilities, including ambulatory surgery centers, urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments and micro-hospitals. In addition, it operates Conifer Health Solutions, LLC through its Conifer Holdings, Inc. (Conifer) subsidiary, which provides revenue cycle management and value-based care services to hospitals, healthcare systems, physician practices, employers and other customers.

Company Coordinates

Company Details

14201 DALLAS PARKWAY , DALLAS TX : 75254

Tel: 1 469 8932200

https://www.tenethealth.com/

Registrar Details